Organization Overview
Alternative names
fludeoxyglucose f-18 (2020)
acetaminophen (tylenol) (3 trials)
amino acids (Freamine) (1 trial)
antithrombin iii (human) (thrombate iii) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (2 trials)
azathioprine (imuran) (1 trial)
basiliximab (simulect) (1 trial)
benzatropine (cogentin) (1 trial)
betamethasone (celestone) (1 trial)
bictegravir (Biktarvy) (1 trial)
bupivacaine (Exparel) (3 trials)
carboplatin (paraplatin) (8 trials)
ceftazidime (fortaz) (1 trial)
ceftriaxone (rocephin) (2 trials)
cyclosporine (sandimmune) (8 trials)
daclizumab (Zenapax) (1 trial)
desogestrel (Mercilon) (3 trials)
dextromethorphan (delsym) (1 trial)
doxycycline (vibramycin) (1 trial)
elexacaftor (Trifakta) (1 trial)
emtricitabine (emtriva) (1 trial)
epinephrine (levophed) (2 trials)
ergocalciferol (drisdol) (1 trial)
estradiol (progynon depot) (5 trials)
ethinyl estradiol (Estinyl) (7 trials)
etoposide (vepesid) (17 trials)
evolocumab (repatha) (2 trials)
hydromorphone (diladid) (1 trial)
insulin human (humulin) (2 trials)
ivacaftor (Kalydeco) (1 trial)
levofloxacin (levaquin) (1 trial)
maraviroc (selzentry) (1 trial)
methylprednisolone (medrol) (6 trials)
mycophenolate (myfortic) (6 trials)
neostigmine (bloxiverz) (1 trial)
omadacycline (nuzyra) (1 trial)
oxycodone (oxycontin) (2 trials)
oxytocin (syntocinon) (3 trials)
pantoprazole (protonix) (1 trial)
progesterone (progestasert) (2 trials)
quetiapine (seroquel) (3 trials)
rifabutin (mycobutin) (1 trial)
sapropterin (kuvan) (2 trials)
somatropin (protropin) (2 trials)
tacrolimus (prograf) (3 trials)
tedizolid phosphate (sivextro) (1 trial)
tezacaftor (Trifakta) (1 trial)
acetylsalicylic acid (aspirin) (2 trials)
allogeneic adipose derived mesenchymal stem cell (1 trial)
atrasentan hydrochloride (1 trial)
autologous bone marrow (4 trials)
autologous hematopoietic cell (1 trial)
benzathine penicillin (1 trial)
bleomycin (blenoxane) (3 trials)
capecitabine (xeloda) (14 trials)
chlorhexidine (hibitane) (2 trials)
cisplatin (platinol) (14 trials)
citalopram (celexa) (2 trials)
colestipol (colestid) (1 trial)
cycloserine (seromycin) (1 trial)
deferasirox (exjade) (2 trials)
dexrazoxane (zinecard) (1 trial)
docetaxel (taxotere) (16 trials)
doxorubicin (Doxil) (15 trials)
filgrastim (neupogen) (3 trials)
fluorouracil (efudex) (14 trials)
icatibant (firazyr) (2 trials)
lovastatin (mevacor) (1 trial)
medroxyprogesterone (provera) (2 trials)
metoclopramide (reglan) (1 trial)
naltrexone (revia) (20 trials)
oxaliplatin (eloxatin) (14 trials)
panitumumab (vectibix) (1 trial)
peripheral blood hematopoietic cell (7 trials)
propranolol (inderal) (1 trial)
ribavirin (virazole) (2 trials)
ropivacaine (naropin) (1 trial)
temozolomide (temodar) (4 trials)
testosterone (delatestryl) (3 trials)
thrombin (bovine) (Thrombostat) (1 trial)
thrombin (human coagulation factor iia) (Recombinant) (Recothrom) (1 trial)
topotecan (hycamtin) (3 trials)
troglitazone (prelay) (1 trial)
vinblastine (velban) (2 trials)
abiraterone (zytiga) (2 trials)
afatinib (gilotrif) (2 trials)
aflibercept (zaltrap) (1 trial)
aldesleukin (proleukin) (3 trials)
alemtuzumab (campath) (3 trials)
allogeneic bone marrow (1 trial)
allogeneic cord blood (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (3 trials)
allogeneic lymphocytes (1 trial)
amphotericin b (fungizone) (1 trial)
arsenic trioxide (trisenox) (3 trials)
asparaginase (elspar) (3 trials)
atezolizumab (tecentriq) (2 trials)
autologous dendritic cells (2 trials)
autologous mesenchymal stem cells (1 trial)
azacitidine (vidaza) (5 trials)
baricitinib (olumiant) (1 trial)
bazedoxifene (Duavee) (1 trial)
benzoyl peroxide (clearasil) (1 trial)
bevacizumab (avastin) (12 trials)
bezlotoxumab (zinplava) (1 trial)
binimetinib (mektovi) (1 trial)
bortezomib (velcade) (8 trials)
cabazitaxel (jevtana kit) (1 trial)
candesartan (atacand) (1 trial)
candida albicans allergen (1 trial)
cemiplimab (libtayo) (2 trials)
clindamycin (cleocin) (1 trial)
cytarabine (cytosar-u) (21 trials)
d1/3-mage-3-his fusion protein (1 trial)
dalteparin (fragmin) (2 trials)
dasatinib (sprycel) (2 trials)
daunorubicin (cerubidine) (4 trials)
decitabine (dacogen) (5 trials)
dinutuximab (unituxin) (3 trials)
docosahexaenoic acid (1 trial)
enoxaparin (lovenox) (1 trial)
enzalutamide (xtandi) (2 trials)
ephb4-hsa fusion protein (7 trials)
erlotinib (tarceva) (2 trials)
estramustine (emcyt) (1 trial)
everolimus (zortress) (2 trials)
f5 tcr transgenic cells (1 trial)
fenofibrate (fenoglide) (1 trial)
fluconazole (diflucan) (1 trial)
fludarabine (fludara) (8 trials)
fulvestrant (faslodex) (1 trial)
gemcitabine (gemzar) (14 trials)
gemtuzumab ozogamicin (mylotarg) (1 trial)
gentamicin (garamycin) (5 trials)
gp-100 peptide vaccine (8 trials)
hla-matched related donor bone marrow (1 trial)
human fecal microbiota (Reybota) (2 trials)
hydrochlorothiazide (esidrix) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
ibritumomab tiuxetan (zevalin) (1 trial)
idarubicin (idamycin) (1 trial)
inactivated influenza vaccine (1 trial)
incomplete freund's adjuvant (7 trials)
indocyanine green (ic-green) (1 trial)
indomethacin (indocin) (1 trial)
infliximab (remicade) (1 trial)
irinotecan (Camptosar) (13 trials)
isotretinoin (accutane) (1 trial)
lenalidomide (revlimid) (2 trials)
lisinopril (zestril) (1 trial)
magnesium sulfate (Tis-U-Sol) (1 trial)
mart-1 peptide pulsed dendritic cells (1 trial)
melphalan (alkeran) (4 trials)
mercaptopurine (purinethol) (3 trials)
methylene blue (proveblue) (1 trial)
metoprolol (lopressor) (1 trial)
minocycline (minocin) (2 trials)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (5 trials)
moxetumomab pasudotox (1 trial)
multi-epitope melanoma peptide vaccine (1 trial)
mx-dng1 retroviral vector (1 trial)
n-(4-hydroxyphenyl)all-trans retinamide (7 trials)
nelarabine (arranon) (1 trial)
nicotine (nicorette) (3 trials)
nifedipine (procardia) (1 trial)
nitroglycerin (transderm-nitro) (1 trial)
octreotide (sandostatin) (1 trial)
omeprazole (prilosec) (1 trial)
oxandrolone (oxandrin) (1 trial)
paclitaxel (taxol) (13 trials)
patient derived cd19 specific car t cells also expressing an egfrt (1 trial)
pravastatin (pravachol) (1 trial)
ramucirumab (cyramza) (1 trial)
regorafenib (stivarga) (2 trials)
rilonacept (arcalyst) (1 trial)
rituximab (rituxan) (5 trials)
romiplostim (nplate) (1 trial)
siltuximab (sylvant) (2 trials)
sitagliptin (januvia) (5 trials)
sorafenib (nexavar) (2 trials)
tamoxifen (nolvadex) (2 trials)
technetium tc-99m sulfur colloid kit (Tesuloid) (1 trial)
temsirolimus (torisel) (3 trials)
tesamorelin (egrifta) (1 trial)
ticagrelor (brilinta) (1 trial)
tinzaparin (Innohep) (1 trial)
tioguanine (Lanvis) (3 trials)
trastuzumab (herceptin) (1 trial)
trimetrexate (neutrexin) (1 trial)
trivirus specific ctls for ebv, cmv and adenovirus infection (1 trial)
tumour infiltrating lymphocytes (1 trial)
unrelated pbsc with t cell depletion (1 trial)
vegf-antisense oligonucleotide (1 trial)
vinorelbine (navelbine) (2 trials)
vorinostat (zolinza) (5 trials)
acetylcysteine (mucomyst) (1 trial)
allogeneic natural killer cells (1 trial)
allogeneic stem cells (1 trial)
betaas3-fb vector transduced bm cd34+ cells (1 trial)
bivalirudin (angiomax) (1 trial)
buthionine sulfoximine (1 trial)
carfilzomib (kyprolis) (1 trial)
elotuzumab (empliciti) (1 trial)
erwinia asparaginase (Erwinaze) (1 trial)
esomeprazole (nexium) (1 trial)
fondaparinux sodium (arixtra) (1 trial)
gadoxetate disodium (eovist) (1 trial)
hydrocortisone (solu-cortef) (1 trial)
ipilimumab (yervoy) (2 trials)
ixabepilone (ixempra) (1 trial)
ketoconazole (nizoral) (1 trial)
lorlatinib (lorbrena) (1 trial)
onabotulinumtoxinA (Botox) (1 trial)
palifermin (kepivance) (1 trial)
panobinostat (farydak) (2 trials)
perflutren protein-type a microspheres (Optison) (4 trials)
albuterol (proventil) (1 trial)
ambrisentan (letairis) (1 trial)
arabinoxylan oligosaccharides (1 trial)
autologous adipose tissue (1 trial)
autologous cd34+ cells (1 trial)
bifidobacterium breve (1 trial)
bifidobacterium infantis (1 trial)
drospirenone (Yasmin) (1 trial)
etravirine (intelence) (1 trial)
fingolimod (gilenya) (1 trial)
fish oil (Omegavan) (2 trials)
gadobenate (multihance) (2 trials)
gadobutrol (gadavist) (1 trial)
gadopenteate dimeglumine (magnevist) (1 trial)
gadoteric acid (Dotarem) (1 trial)
granisetron (kytril) (1 trial)
hexyl 5-aminolevulinate (Cysview) (1 trial)
Lactobacillus acidophilus (1 trial)
lactulose (cephulac) (1 trial)
lansoprazole (prevacid) (1 trial)
levalbuterol (xopenex) (1 trial)
levobupivacaine (chirocaine) (2 trials)
levocarnitine (carnitor) (1 trial)
lymphocyte immune globulin, anti-thymocyte globulin (equine) (Atgam) (1 trial)
mifepristone (mifeprex) (1 trial)
olanzapine (zyprexa) (1 trial)
platelet rich plasma (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
Acute Disease (Phase 1)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Mucinous (Phase 2)
Adenoviridae Infections (Phase 2)
Adrenal Hyperplasia, Congenital (Phase 1)
Adrenocortical Hyperfunction (Phase 1)
Adrenogenital Syndrome (Phase 1)
Alzheimer Disease (Phase 3)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Sickle Cell (Phase 3)
Angioedema (Phase 3)
Angioedemas, Hereditary (Phase 3)
Anhedonia (Phase 2)
Anovulation (Phase 4)
Apnea (Phase 2)
Arterial Occlusive Diseases (Phase 3)
Arteriosclerosis (Phase 4)
Arthralgia (Phase 2)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Asphyxia (Phase 3)
Asphyxia Neonatorum (Phase 3)
Atherosclerosis (Phase 4)
Atrophy (Phase 3)
Behavior, Addictive (Phase 1)
beta-Thalassemia (Phase 2)
Bile Duct Neoplasms (Phase 2)
Brain Diseases (Phase 3)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 1)
Bronchiolitis (Phase 3)
Bronchopulmonary Dysplasia (Phase 4)
Burkitt Lymphoma (Phase 2)
Calcinosis (Phase 4)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Ductal (Phase 2)
Carcinoma, Ductal, Breast (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma in Situ (Phase 2)
Carcinoma, Intraductal, Noninfiltrating (Phase 2)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Medullary (Phase 1)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 3)
Carotid Body Tumor (Phase 1)
Carpal Tunnel Syndrome (Phase 2)
Central Nervous System Neoplasms (Phase 3)
Cerebral Hemorrhage (Phase 2)
Cerebral Palsy (Phase 2)
Cerebrovascular Disorders (Phase 3)
Cholangiocarcinoma (Phase 2)
Cholangitis (Phase 4)
Cholangitis, Sclerosing (Phase 1)
Clostridium Infections (Phase 2)
Cognition Disorders (Phase 3)
Cognitive Dysfunction (Phase 3)
Colitis (Phase 1)
Colitis, Ulcerative (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 2)
Constipation (Phase 4)
Contracture (Phase 2)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Critical Illness (Phase 2)
Crohn Disease (Phase 2)
Cystadenocarcinoma (Phase 2)
Cystic Fibrosis (Phase 4)
Deafness (Phase 1)
Death, Sudden (Phase 3)
Death, Sudden, Cardiac (Phase 3)
Dementia (Phase 1)
Depression (Phase 3)
De Quervain Disease (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetic Foot (Phase 2)
Diarrhea (Phase 2)
Down Syndrome (Phase 2)
Duodenal Neoplasms (Phase 1)
Dupuytren Contracture (Phase 2)
Dwarfism, Pituitary (Phase 4)
Dyskeratosis Congenita (Phase 2)
Dystonia (Phase 2)
Dystonic Disorders (Phase 2)
Emergencies (Phase 4)
Endocrine System Diseases (Phase 4)
Endometrial Hyperplasia (Phase 2)
Endometrial Neoplasms (Phase 2)
End Stage Liver Disease (Phase 4)
Ependymoma (Phase 2)
Epidermolysis Bullosa (Phase 2)
Epidermolysis Bullosa Dystrophica (Phase 2)
Epidermolysis Bullosa, Junctional (Phase 2)
Epilepsy (Phase 3)
Epstein-Barr Virus Infections (Phase 2)
Esophageal Neoplasms (Phase 2)
Fibrosis (Phase 4)
Finger Injuries (Phase 2)
Food Hypersensitivity (Phase 2)
Foot Ulcer (Phase 2)
Frailty (Phase 2)
Gallbladder Neoplasms (Phase 2)
Ganglion Cysts (Phase 2)
Gastrinoma (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Genetic Diseases, Inborn (Phase 2)
Germinoma (Phase 1)
Glioma (Phase 2)
Glucagonoma (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Hearing Loss (Phase 1)
Heart Diseases (Phase 3)
Heart Failure (Phase 4)
Hemorrhage (Phase 2)
Hemosiderosis (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis, Alcoholic (Phase 2)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatoblastoma (Phase 3)
Hernia (Phase 4)
Hernia, Diaphragmatic (Phase 4)
Hernias, Diaphragmatic, Congenital (Phase 4)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 1)
Hyperplasia (Phase 2)
Hypersensitivity (Phase 1)
Hypertension (Phase 4)
Hypertension, Pregnancy-Induced (Phase 4)
Hypertension, Pulmonary (Phase 4)
Hypogonadism (Phase 2)
Hypopituitarism (Phase 4)
Immunologic Deficiency Syndromes (Phase 2)
Infarction (Phase 3)
Infections (Phase 4)
Inflammation (Phase 4)
Insulinoma (Phase 2)
Insulin Resistance (Phase 2)
Intracranial Arteriosclerosis (Phase 3)
Iron Overload (Phase 3)
Ischemia (Phase 4)
Kidney Diseases (Phase 2)
Kidney Neoplasms (Phase 2)
Laboratory Infection (Phase 2)
Leukemia (Phase 2)
Leukemia, Erythroblastic, Acute (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 1)
Leukemia, Monocytic, Acute (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 2)
Liver Cirrhosis (Phase 3)
Liver Diseases (Phase 4)
Liver Neoplasms (Phase 3)
Lung Neoplasms (Phase 2)
Lymphedema (Phase 2)
Lymphoma (Phase 2)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, Primary Effusion (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphoproliferative Disorders (Phase 2)
Macular Edema (Phase 2)
Malignant Carcinoid Syndrome (Phase 2)
Medulloblastoma (Phase 4)
Melanoma (Phase 2)
Meningitis (Phase 2)
Meningitis, Cryptococcal (Phase 2)
Mental Disorders (Phase 3)
Mesothelioma (Phase 2)
Metabolic Diseases (Phase 2)
Mood Disorders (Phase 3)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 3)
Muscle Weakness (Phase 2)
Muscular Atrophy (Phase 3)
Myalgia (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 1)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 4)
Neoplasms, Neuroepithelial (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Neuroendocrine Tumors (Phase 2)
Obesity (Phase 2)
Osteoporosis (Phase 3)
Osteosarcoma (Phase 3)
Ovarian Neoplasms (Phase 2)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 2)
Paraganglioma (Phase 1)
Pemphigus (Phase 2)
Periapical Periodontitis (Phase 3)
Periodontitis (Phase 3)
Peripheral Arterial Disease (Phase 4)
Peripheral Vascular Diseases (Phase 4)
Peritoneal Neoplasms (Phase 2)
Phenylketonurias (Phase 4)
Pheochromocytoma (Phase 1)
Philadelphia Chromosome (Phase 1)
Plasmacytoma (Phase 1)
Polycystic Kidney, Autosomal Dominant (Phase 2)
Polycystic Kidney Diseases (Phase 2)
Precancerous Conditions (Phase 1)
Pre-Eclampsia (Phase 4)
Preleukemia (Phase 2)
Prostatic Neoplasms (Phase 3)
Psychomotor Agitation (Phase 3)
Psychotic Disorders (Phase 3)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 1)
Respiration Disorders (Phase 2)
Respiratory Tract Diseases (Phase 2)
Rotator Cuff Injuries (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 3)
Sarcopenia (Phase 2)
Sclerosis (Phase 3)
Sepsis (Phase 3)
Septo-Optic Dysplasia (Phase 4)
Severe Combined Immunodeficiency (Phase 2)
Shoulder Pain (Phase 4)
Skin Neoplasms (Phase 2)
Sleep Apnea, Obstructive (Phase 2)
Sleep Apnea Syndromes (Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Soft Tissue Neoplasms (Phase 2)
Somatostatinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Stress Disorders, Post-Traumatic (Phase 3)
Stress Disorders, Traumatic (Phase 3)
Stroke (Phase 2)
Surgical Wound Infection (Phase 2)
Syndrome (Phase 2)
Synovial Cyst (Phase 2)
Testicular Neoplasms (Phase 2)
Thalassemia (Phase 2)
Thrombocytopenia (Phase 2)
Thromboembolism (Phase 2)
Thrombosis (Phase 1)
Tobacco Use Disorder (Phase 4)
Trigger Finger Disorder (Phase 2)
Triple Negative Breast Neoplasms (Phase 1)
Ulcer (Phase 2)
Ureteral Neoplasms (Phase 2)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urinary Bladder, Overactive (Phase 4)
Uterine Cervical Neoplasms (Phase 2)
Uveal Neoplasms (Phase 2)
Vascular Diseases (Phase 2)
Venous Thromboembolism (Phase 2)
Venous Thrombosis (Phase 1)
Ventricular Fibrillation (Phase 3)
Vitamin B 12 Deficiency (Phase 1)
Vitamin D Deficiency (Phase 2)
Wiskott-Aldrich Syndrome (Phase 2)
Wounds and Injuries (Phase 2)
Xerostomia (Phase 4)